Gene · 1364
Papers3,919
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,919
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Implantation and Decidualization in PCOS: Unraveling the Complexities of Pregnancy. | Int J Mol Sci | 2024 | 38256276 | PubTator, text mining | PubMed |
| An Overview of Advances in Rare Cancer Diagnosis and Treatment. | Int J Mol Sci | 2024 | 38256274 | PubTator, text mining | PubMed |
| The TGF-β Family in Glioblastoma. | Int J Mol Sci | 2024 | 38256140 | PubTator, text mining | PubMed |
| Differential Modulation of Mouse Intestinal Organoids with Fecal Luminal Factors from Obese, Allergic, Asthmatic Children. | Int J Mol Sci | 2024 | 38255939 | PubTator, text mining | PubMed |
| Alkaline Phosphatase Relieves Colitis in Obese Mice Subjected to Forced Exercise via Its Anti-Inflammatory and Intestinal Microbiota-Shaping Properties. | Int J Mol Sci | 2024 | 38255781 | PubTator, text mining | PubMed |
| The Relationship between Fine Particle Matter (PM2.5) Exposure and Upper Respiratory Tract Diseases. | J Pers Med | 2024 | 38248800 | PubTator, text mining | PubMed |
| Cannabidiol Strengthening of Gastric Tight Junction Complexes Analyzed in an Improved Xenopus Oocyte Assay. | Membranes (Basel) | 2024 | 38248708 | PubTator, text mining | PubMed |
| An immune-related exosome signature predicts the prognosis and immunotherapy response in ovarian cancer. | BMC Womens Health | 2024 | 38238671 | PubTator, text mining | PubMed |
| NSUN2-Mediated m5C Methylation Impairs Endometrial Receptivity. | Lab Invest | 2024 | 38237738 | PubTator, text mining | PubMed |
| Lung Epithelial Regnase-1 Dampens Local Immune Response but Does Not Worsen Susceptibility to Klebsiella pneumoniae. | Immunohorizons | 2024 | 38226923 | PubTator, text mining | PubMed |
| Chronic constipation in Parkinson's disease: clinical features and molecular insights on the intestinal epithelial barrier. | Ann Gastroenterol | 2024 | 38223240 | PubTator, text mining | PubMed |
| A novel Trichinella spiralis serine proteinase disrupted gut epithelial barrier and mediated larval invasion through binding to RACK1 and activating MAPK/ERK1/2 pathway. | PLoS Negl Trop Dis | 2024 | 38190388 | PubTator, text mining | PubMed |
| Zolbetuximab for Claudin18.2-positive gastric or gastroesophageal junction cancer. | Ther Adv Med Oncol | 2024 | 38188462 | PubTator, text mining | PubMed |
| Claudins and hepatocellular carcinoma. | Biomed Pharmacother | 2024 | 38185042 | PubTator, text mining | PubMed |
| Comparative single-cell analysis reveals heterogeneous immune landscapes in adenocarcinoma of the esophagogastric junction and gastric adenocarcinoma. | Cell Death Dis | 2024 | 38182569 | PubTator, text mining | PubMed |
| In vitro faecal fermentation of Tritordeum breads and its effect on the human gut health. | Curr Res Microb Sci | 2024 | 38116184 | PubTator, text mining | PubMed |
| Estrogen receptor beta suppresses the androgen receptor oncogenic effects in triple-negative breast cancer. | Chin Med J (Engl) | 2024 | 38105538 | PubTator, text mining | PubMed |
| VPS35 promotes gastric cancer progression through integrin/FAK/SRC signalling-mediated IL-6/STAT3 pathway activation in a YAP-dependent manner. | Oncogene | 2024 | 37950040 | PubTator, text mining | PubMed |
| Claudin-4 immunocytochemistry is specific and sensitive for the diagnosis of malignant carcinomatous effusions: Results from a pilot study. | Diagn Cytopathol | 2024 | 37837242 | PubTator, text mining | PubMed |
| Benvitimod Inhibits IL-4- and IL-13-Induced Tight Junction Impairment by Activating AHR/ARNT Pathway and Inhibiting STAT6 Phosphorylation in Human Keratinocytes. | J Invest Dermatol | 2024 | 37734479 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1364/papers?page=13